The Medicines and Healthcare products Regulatory Agency (MHRA), which regulates drugs and devices in the UK, has updated its advice concerning the increased risk of lower limb amputation associated with canaglifozin, a drug used to treat type 2 diabetes.
Researchers have identified the drug classes that are frequently implicated in causing acute kidney injury after analysing adverse drug reactions in a French national pharmacovigilance database.
A study of 3,660 patients across eight countries has identified the types of inhaler technique errors that are associated with the greatest impact on asthma outcomes.
New mantra should be to get cholesterol as low as possible, researchers conclude.
Researchers find that blood clot rates in patients taking rivaroxaban were significantly lower than those taking aspirin, and there were no significant differences between bleeding side effects.
Lawyers representing health secretary Jeremy Hunt have defended his decision to slice more than £320m off the community pharmacy budget in England.
Healthcare professionals have been reminded of the fire risk associated with paraffin-containing skin creams, following a BBC radio programme that highlighted the potential dangers.
The National Pharmacy Association, a trade association representing independent pharmacy owners, has added its weight to the legal attack on government plans to slash £320m off the community pharmacy budget.
Patients in Wales will no longer have to prove they have “exceptional clinical circumstances” in order to access drugs that are not routinely available on the NHS.
The impact of the government slashing more than £320m from the community pharmacy budget in England was spelt out to a High Court judge on 21 March 2017 as the legal challenge to the cuts began.
The legal challenges to the government’s decision to cut the community pharmacy budget in England — first announced in December 2015 — are due to begin in the High Court on 21 March 2017.
Business confidence among community pharmacists in England has fallen to a record low, according to the results of the annual Lloyds Bank Commercial Banking Healthcare Confidence Index.
Financial pressures on the NHS are harming community-based services, while some acute services are being shielded from cuts, putting the NHS ‘Five year forward view’ at risk, according to an analysis by The King’s Fund.
The General Pharmaceutical Council (GPhC) has appointed Megan Forbes as its deputy chief executive and director of operations, effective from 5 June 2017.
Researchers found small decreases in blood pressure and heart rate in patients treated with guanfacine, and say further clinical testing is needed.
Opioid-receptor agonist demonstrated similar level of pain relief to fentanyl but without typical side effects associated with opioids.
Researchers found that smokers who relapsed while trying to quit had a reduced functional connectivity between brain regions involved in inhibitory control, compared to those who remained abstinent.
Adding pravastatin to platinum-based chemotherapy offered no benefit to survival compared with placebo, researchers report.
Scientists find a new chemical probe that is a potent inhibitor of human cancer cell proliferation in vitro, with potential applications against many cancers.
Researchers say their study using a mouse model of chronic social defeat stress could be applied to identify novel drug targets for depression therapies.
Animal research suggests that frequent consumption of aspirin could contribute to S. aureus infection.
Researchers found that a single dose of their mRNA-based Zika vaccine could protect mice for up to five months.